Flow chart of the study.
- Susanne H. Sheehy (182297)
- Christopher J. A. Duncan (182299)
- Sean C. Elias (182305)
- Sumi Biswas (137589)
- Katharine A. Collins (182313)
- Geraldine A. O'Hara (182319)
- Fenella D. Halstead (182325)
- Katie J. Ewer (182328)
- Tabitha Mahungu (182333)
- Alexandra J. Spencer (40854)
- Kazutoyo Miura (35285)
- Ian D. Poulton (182342)
- Matthew D. J. Dicks (151161)
- Nick J. Edwards (151165)
- Eleanor Berrie (182346)
- Sarah Moyle (182349)
- Stefano Colloca (182351)
- Riccardo Cortese (7724)
- Katherine Gantlett (182354)
- Carole A. Long (35289)
- Alison M. Lawrie (182358)
- Sarah C. Gilbert (36739)
- Tom Doherty (182363)
- Alfredo Nicosia (182367)
- Adrian V. S. Hill (40512)
- Simon J. Draper (124426)
Publication date
February 2012
DOIAbstract
<p>All vaccinations were administered intramuscularly. ChAd63 AMA1 was administered on day 0 and MVA AMA1 on day 56. Six volunteers were excluded following screening for the following reasons: psychiatric morbidity; recurrent severe urticaria; elevated alanine aminotransferase (87 IU/L); unexplained microscopic haematuria and proteinuria; and withdrawal of consent (two individuals).</p
Add to ORKG